Locations:

News & Insight

August 25, 2021/Cancer/News & Insight

Inotuzumab Ozogamicin Improves Outcomes in Patients With Acute Lymphoblastic Leukemia, Independent of CD22 Expression

Drug beats standard care for the treatment of relapsed or refractory ALL

January 25, 2021/Cancer/News & Insight

The Cancer Center and Cleveland Clinic’s Centennial

Reflecting on our progress and potential

January 21, 2021/Cancer/News & Insight

Managing CAR T-Cell Therapy Across Cancer Center Programs

Researching and operationalizing a new therapy

January 19, 2021/Cancer/News & Insight

COVID-19 mRNA Vaccines: What Does This Mean for Cancer?

Insights from the Director of the Center for Immunotherapy and Precision Immuno-Oncology

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 18, 2020/Cancer/News & Insight

Combination Therapy for AL Amyloidosis Safe, Tolerable and Promising in Early Results

Cael-101 + CyBorD dosing and outcomes

August 25, 2020/Cancer/News & Insight

Artificial Intelligence Initiative in Oncology Receives NCI Grant

Cleveland Clinic and Case Western researchers on the forefront

June 22, 2020/Cancer/News & Insight

Learning from Leukemia

A Cleveland Clinic oncologist’s book reflects on patients’ and physicians’ shared journeys

June 15, 2020/Cancer/News & Insight

Prioritizing Patients with Rare Cancers and Blood Disorders

Initiative improves access to specialists, advanced treatments

Cleveland-Clinic_Taussig_DuskFacade_FromSouthWest-650×433

April 20, 2020/Cancer/News & Insight

How to Continue Caring for Cancer Patients During the Pandemic

Advice from the leader of Cleveland Clinic Cancer Center

April 6, 2020/Cancer/News & Insight

Managing Lung Cancer Patients During the COVID-19 Pandemic

Webinar series provides expert insights

BackPage 6 of 9Next